Tokyo Tape
Sign in
← PHC Holdings

Half-year report · HY

6523.TEDINET S100X235
Period2025-04-01 → 2025-09-30
Filed2025-11-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥173.4bn2025-04-01 → 2025-09-30Cons.Revenue IFRS
Revenue¥361.6bn2024-04-01 → 2025-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥173.9bn2024-04-01 → 2024-09-30Cons.Revenue IFRS
Operating income¥10.4bn2025-04-01 → 2025-09-30Cons.Operating profit loss IFRS
Operating income¥9.2bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Profit before tax¥941m2025-04-01 → 2025-09-30Cons.Profit loss before tax IFRS
Profit before tax¥18.8bn2024-04-01 → 2025-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥7.4bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Net income (owners)−¥559m2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥10.5bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥4.1bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income−¥692m2025-04-01 → 2025-09-30Cons.Profit loss IFRS
Net income¥4.0bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Total assets¥525.8bnat 2025-09-30Cons.Assets IFRS
Total assets¥532.5bnat 2025-03-31Cons.Assets IFRS
Total assets¥525.4bnat 2024-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥379.8bnat 2025-09-30Cons.Liabilities IFRS
Total liabilities¥391.3bnat 2025-03-31Cons.Liabilities IFRS
Net assets / equity¥146.0bnat 2025-09-30Cons.Equity IFRS
Net assets / equity¥141.2bnat 2025-03-31Cons.Equity IFRS
Net assets / equity¥127.4bnat 2024-09-30Cons.Equity IFRS
Net assets / equity¥139.2bnat 2024-03-31vCons.Equity IFRS
Equity (owners)¥146.7bnat 2025-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥141.6bnat 2025-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥127.8bnat 2024-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥33.3bnat 2025-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥39.6bnat 2025-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥33.0bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥47.0bnat 2024-03-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥12.1bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥41.9bn2024-04-01 → 2025-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥13.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥4.2bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥8.5bn2024-04-01 → 2025-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥5.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥17.6bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥39.1bn2024-04-01 → 2025-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥20.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-4.422025-04-01 → 2025-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥83.132024-04-01 → 2025-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥32.522024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥-4.422025-04-01 → 2025-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥82.582024-04-01 → 2025-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥32.422024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio27.9%at 2025-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio26.6%at 2025-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.3%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2025-04-01 → 2025-09-30¥2.9bn
Reconciling Itemsreconcilingrevenue external2025-04-01 → 2025-09-30¥2.9bn
Reconciling Itemsreconcilingsegment profit2025-04-01 → 2025-09-30−¥3.2bn
Diabetes Managementreportable segmentrevenue2025-04-01 → 2025-09-30¥48.7bn
Diabetes Managementreportable segmentrevenue external2025-04-01 → 2025-09-30¥48.7bn
Diabetes Managementreportable segmentsegment profit2025-04-01 → 2025-09-30¥9.3bn
Diagnostics And Life Sciencesreportable segmentrevenue2025-04-01 → 2025-09-30¥59.1bn
Diagnostics And Life Sciencesreportable segmentrevenue external2025-04-01 → 2025-09-30¥59.1bn
Diagnostics And Life Sciencesreportable segmentsegment profit2025-04-01 → 2025-09-30¥1.3bn
Healthcare Solutionsreportable segmentrevenue2025-04-01 → 2025-09-30¥62.7bn
Healthcare Solutionsreportable segmentrevenue external2025-04-01 → 2025-09-30¥62.7bn
Healthcare Solutionsreportable segmentsegment profit2025-04-01 → 2025-09-30¥3.0bn
—segment totalrevenue2025-04-01 → 2025-09-30¥170.5bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥170.5bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥13.6bn
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30¥1.6bn
Reconciling Itemsreconcilingrevenue external2024-04-01 → 2024-09-30¥1.6bn
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥4.3bn
Diabetes Managementreportable segmentrevenue2024-04-01 → 2024-09-30¥48.3bn
Diabetes Managementreportable segmentrevenue external2024-04-01 → 2024-09-30¥48.3bn
Diabetes Managementreportable segmentsegment profit2024-04-01 → 2024-09-30¥6.4bn
Diagnostics And Life Sciencesreportable segmentrevenue2024-04-01 → 2024-09-30¥62.6bn
Diagnostics And Life Sciencesreportable segmentrevenue external2024-04-01 → 2024-09-30¥62.6bn
Diagnostics And Life Sciencesreportable segmentsegment profit2024-04-01 → 2024-09-30¥3.5bn
Healthcare Solutionsreportable segmentrevenue2024-04-01 → 2024-09-30¥61.5bn
Healthcare Solutionsreportable segmentrevenue external2024-04-01 → 2024-09-30¥61.5bn
Healthcare Solutionsreportable segmentsegment profit2024-04-01 → 2024-09-30¥3.6bn
—segment totalrevenue2024-04-01 → 2024-09-30¥172.3bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥172.3bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥13.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 753
ItemContextValueUnit
Diluted earnings loss per share IFRSPrior1InterimDuration32.42
Diluted earnings loss per share IFRSInterimDuration-4.42
Profit loss IFRSPrior1InterimDuration4022000000JPY
Profit loss IFRSInterimDuration-692000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1InterimDuration-770000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSInterimDuration211000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1InterimDuration-2114000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSInterimDuration-2418000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1InterimDuration43000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSInterimDuration0JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1InterimDuration-10709000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSInterimDuration10520000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSPrior1InterimDuration-97000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSInterimDuration-383000000JPY
Other comprehensive income IFRSPrior1InterimDuration-13648000000JPY
Other comprehensive income IFRSInterimDuration7928000000JPY
Comprehensive income IFRSPrior1InterimDuration-9626000000JPY
Comprehensive income IFRSInterimDuration7236000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1InterimDuration-9563000000JPY
Comprehensive income attributable to owners of parent IFRSInterimDuration7385000000JPY
Comprehensive income attributable to non controlling interests IFRSPrior1InterimDuration-62000000JPY
Comprehensive income attributable to non controlling interests IFRSInterimDuration-148000000JPY
Comprehensive income IFRSPrior1InterimDuration-9626000000JPY
Comprehensive income IFRSInterimDuration7236000000JPY
Equity IFRSPrior2YearInstant_ShareCapitalIFRSMember48423000000JPY
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember41797000000JPY
Equity IFRSPrior2YearInstant_RetainedEarningsIFRSMember-2773000000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-568000000JPY
Equity IFRSPrior2YearInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Equity IFRSPrior2YearInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-1110000000JPY
Equity IFRSPrior2YearInstant_EffectivePortionOfCashFlowHedgesIFRSMember-3000000JPY
Profit loss IFRSPrior1InterimDuration_ShareCapitalIFRSMember－JPY
Profit loss IFRSPrior1InterimDuration_CapitalSurplusIFRSMember－JPY
Profit loss IFRSPrior1InterimDuration_RetainedEarningsIFRSMember4100000000JPY
Profit loss IFRSPrior1InterimDuration_TreasurySharesIFRSMember－JPY
Profit loss IFRSPrior1InterimDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Profit loss IFRSPrior1InterimDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Profit loss IFRSPrior1InterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Other comprehensive income IFRSPrior1InterimDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSPrior1InterimDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSPrior1InterimDuration_RetainedEarningsIFRSMember－JPY
Other comprehensive income IFRSPrior1InterimDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSPrior1InterimDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-770000000JPY
Other comprehensive income IFRSPrior1InterimDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-2114000000JPY
Other comprehensive income IFRSPrior1InterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember43000000JPY
Comprehensive income IFRSPrior1InterimDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSPrior1InterimDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSPrior1InterimDuration_RetainedEarningsIFRSMember4100000000JPY
Comprehensive income IFRSPrior1InterimDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSPrior1InterimDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-770000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2025-03-31pass rounding
balance sheet identityconsolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass